Ryan Savitz - 03 Feb 2025 Form 4 Insider Report for Dianthus Therapeutics, Inc. /DE/ (DNTH)

Role
CFO & CBO
Signature
/s/ Adam Veness, as attorney-in-fact for Ryan Savitz
Issuer symbol
DNTH
Transactions as of
03 Feb 2025
Net transactions value
$0
Form type
4
Filing time
04 Feb 2025, 16:18:46 UTC
Previous filing
28 May 2024
Next filing
11 Sep 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNTH Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 03 Feb 2025 Common Stock 150,000 $22.07 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.